TPG, a US-based private equity investment firm, has completed the acquisition of Optum UK from UnitedHealth Group in a transaction valued at approximately $400 million. Optum UK owns and operates EMIS, software that manages electronic patient records across more than half of all general practitioner practices in England, giving the company responsibility for healthcare data belonging to millions of NHS patients.
The transaction has drawn criticism from medical professionals, campaigners, parliamentarians, and human rights advocates who express concern that the transfer occurred with minimal public discussion or parliamentary involvement. Doctors’ Association UK stated that private equity firms now effectively control the foundational technology infrastructure of English general practice, raising questions about whether business models focused on investor returns can adequately prioritize patient care. Liberal Democrats health spokesperson Helen Morgan characterized such arrangements as being approved without sufficient scrutiny or protective measures for patients and called for the government to support British technology companies instead.
Scrutiny of the deal has also centered on TPG’s international healthcare operations. Earlier this year, an investigation by the International Consortium of Investigative Journalists examined hospitals in Kenya owned by Evercare, a healthcare organization backed by TPG’s Rise Fund. The investigation reported allegations that patients at these facilities faced substantial debt burdens, with some required to provide land deeds as collateral for unpaid medical bills. TPG disputed these characterizations, stating it has invested more than $100 million in Evercare over six years, resulting in improvements to quality, accessibility, and patient rights protections.
Anna Marriott, former health policy lead at Oxfam, stated that private equity firms with controversial international healthcare records should not be permitted to control NHS patient data with insufficient public oversight. She argued that regulatory safeguards have not kept pace with the expanding involvement of private equity in health services. Both EMIS and TPG have provided statements asserting that the acquisition does not alter existing data protection standards, security protocols, or regulatory compliance obligations. EMIS noted the transaction was reviewed and approved by the UK government under the National Security and Investment Act 2021. The Department of Health and Social Care did not provide comment on the acquisition.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI